Visualization of Fibroblast Activation After Myocardial Infarction Using 68Ga-FAPI PET

68Ga-FAPI-04 Accumulation in Myocardial Infarction in a Patient With Neuroendocrine Carcinoma

(2020) Wenjia Zhu et al.   CLINICAL NUCLEAR MEDICINE

Fibroblast Activation Protein Inhibitor PET/CT

(2020) Punit Sharma et al.   CLINICAL NUCLEAR MEDICINE

Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy

(2019) Malte Kircher et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer

(2019) Clemens Kratochwil et al.   JOURNAL OF NUCLEAR MEDICINE

Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials

(2019) Susan Stienen et al.   Clinical Research in Cardiology

Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labelled fibroblast activation protein inhibitor FAPI-04

(2019) Zohreh Varasteh et al.   JOURNAL OF NUCLEAR MEDICINE

Development of quinoline based theranostic ligands for the targeting of fibroblast activation protein

(2018) Thomas Lindner et al.   JOURNAL OF NUCLEAR MEDICINE

FAPI-PET/CT: biodistribution and preliminary dosimetry estimate of two DOTA-containing FAP-targeting agents in patients with various cancers

(2018) Frederik Giesel et al.   JOURNAL OF NUCLEAR MEDICINE

Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps

(2017) Yonggang Ma et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

How does fibrosis promote atrial fibrillation persistence:in silicofindings, clinical observations, and experimental data

(2016) Stanley Nattel   CARDIOVASCULAR RESEARCH

Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration

(2016) Virpi Talman et al.   CELL AND TISSUE RESEARCH

Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study

(2016) W. P. Law et al.   JOURNAL OF NUCLEAR MEDICINE

The Living Scar – Cardiac Fibroblasts and the Injured Heart

(2016) Eva A. Rog-Zielinska et al.   TRENDS IN MOLECULAR MEDICINE

Targeting danger-associated molecular patterns after myocardial infarction

(2015) Gerardus PJ van Hout et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction

(2015) Jochen Tillmanns et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography

(2014) Sharmila Dorbala et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy

(2013) Vibeke M. Almaas et al.   EUROPACE

Fibroblasts in myocardial infarction: A role in inflammation and repair

(2013) Arti V. Shinde et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Atrial Remodeling and Atrial Fibrillation

(2008) Stanley Nattel et al.   Circulation-Arrhythmia and Electrophysiology

Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

(2008) Stanley Chia et al.   JACC-Cardiovascular Interventions